Gene · 60468
Papers1,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,982
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic regulation during cancer transitions across 11 tumour types. | Nature | 2023 | 37914932 | PubTator, text mining | PubMed |
| Unraveling the Immunopathological Landscape of Celiac Disease: A Comprehensive Review. | Int J Mol Sci | 2023 | 37895160 | PubTator, text mining | PubMed |
| MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas. | Int J Mol Sci | 2023 | 37894763 | PubTator, text mining | PubMed |
| New Insights on Sperm Function in Male Infertility of Unknown Origin: A Multimodal Approach. | Biomolecules | 2023 | 37892144 | PubTator, text mining | PubMed |
| Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy. | J Hematol Oncol | 2023 | 37880715 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma. | EBioMedicine | 2023 | 37879219 | PubTator, text mining | PubMed |
| Necroptosis-related genes are associated with prognostic features of kidney renal clear cell carcinoma. | Discov Oncol | 2023 | 37878133 | PubTator, text mining | PubMed |
| Characteristics of premanufacture CD8+T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma. | Signal Transduct Target Ther | 2023 | 37875502 | PubTator, text mining | PubMed |
| Active maintenance of CD8+ T cell naivety through regulation of global genome architecture. | Cell Rep | 2023 | 37858463 | PubTator, text mining | PubMed |
| Trimodal single-cell profiling reveals a novel pediatric CD8αα+ T cell subset and broad age-related molecular reprogramming across the T cell compartment. | Nat Immunol | 2023 | 37845489 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity. | Cell Death Dis | 2023 | 37833255 | PubTator, text mining | PubMed |
| PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders. | Front Immunol | 2023 | 37809097 | PubTator, text mining | PubMed |
| circ_SPEF2 Regulates the Balance of Treg Cells by Regulating miR-16-5p/BACH2 in Lymphoma and Participates in the Immune Response. | Tissue Eng Regen Med | 2023 | 37801226 | PubTator, text mining | PubMed |
| Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy. | Immunotargets Ther | 2023 | 37795196 | PubTator, text mining | PubMed |
| Renal involvement in eosinophilic granulomatosis with polyangiitis. | Front Med (Lausanne) | 2023 | 37790127 | PubTator, text mining | PubMed |
| Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis. | Arthritis Res Ther | 2023 | 37784141 | PubTator, text mining | PubMed |
| Innate immune response restarts adaptive immune response in tumors. | Front Immunol | 2023 | 37781382 | PubTator, text mining | PubMed |
| Medical Challenges of a Common Variable Immunodeficiency With a TNFRSF13B Gene Mutation in a Simultaneous Kidney and Pancreas Transplant Recipient. | Cureus | 2023 | 37767270 | PubTator, text mining | PubMed |
| Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations. | J Clin Med | 2023 | 37762936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60468/papers?page=12